Macquarie Group’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
GCL
TAL
HI
BCM
MF
Macquarie Group's SWTX Position: Q2 2025 in Review
Macquarie Group sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 46,405 shares — an estimated $2.05M sold.
Macquarie Group first reported a position in SWTX in Q2 2020 and held it in 20 quarters. The position peaked at $2.05M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.
- Macquarie Group reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
- Macquarie Group sold 46,405 SpringWorks Therapeutics shares in Q2 2025, an estimated $2.05M.
- Macquarie Group first reported a position in SpringWorks Therapeutics in Q2 2020 and held it in 20 quarters.
- Macquarie Group's SpringWorks Therapeutics position peaked at $2.05M in Q1 2025.
- 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.
Based on Macquarie Group's 13F filing for Q2 2025, filed 14 Aug 2025.